Search or
𝛼SK
𝛼SKSign in with Google. Opens in new tab
bullish
"Exchange Arbitrage" For Early-Stage Biotech!
576 Views20 Jan 2018 21:30
Hong Kong Exchanges and Clearing Limited (HKEX) has decided to modify its rules to allow "pre-commercial" biopharmaceutical (aka biotechnology)...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Taiwan Top 50 ETF Rebalance Preview: Another Inclusion for King Slide
- [Japan M&A] Founder, KEPCO, Try ÂĄ2,750 Bain-Led MBO on Rezil (176A). Light Given Growth - Bumpity?
- [Japan M&A] Minebea Matches YAGEO for Shibaura Elec (6957) At ÂĄ6,200. Presses on Early Cashout
- HMM: Tender Offer of 8% of Outstanding Shares and Cancellation
- Pre-IPO Guangzhou Innogen Pharmaceutical Group (PHIP Updates) - Some Points Worth the Attention
Top Unpaywalled Insights
More »- [IO Technicals 2025/33] China Woes Deepen, Bearish Momentum Grips Iron Ore
- Tradesmen's Collective: Fixing the Trades with Tech, Transparency & Boots-on-the-Ground
- VEON 2Q25: Solid Digital Non-Telco Products Uplift, Kyivstar Listing in Focus
- [IO Technicals 2025/32] Bullish Momentum Builds
- Grab Holdings (GRAB US) - Harvesting Sequentially
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- WuXi Biologics – The Foxconn or Qualcomm of Global CDMO?13 Jan 2019
- "Exchange Arbitrage" For Early-Stage Biotech!20 Jan 2018
- WuXi Biologics: Pass on This Valuation26 May 2017
- WuXi Biologics: Updated Valuation Data16 May 2017
- An Early Look at WuXi Biologics14 Feb 2017
x